Home Other Building Blocks 3-(4-phenylpiperazin-1-yl)propane-1,2-diol

3-(4-phenylpiperazin-1-yl)propane-1,2-diol

CAS No.:
17692-31-8
Catalog Number:
AG0024ZO
Molecular Formula:
C13H20N2O2
Molecular Weight:
236.3101
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%
In Stock USA
United States
$19
- +
5g
98%
In Stock USA
United States
$44
- +
25g
98%
In Stock USA
United States
$175
- +
100g
98%
In Stock USA
United States
$525
- +
Product Description
Catalog Number:
AG0024ZO
Chemical Name:
3-(4-phenylpiperazin-1-yl)propane-1,2-diol
CAS Number:
17692-31-8
Molecular Formula:
C13H20N2O2
Molecular Weight:
236.3101
MDL Number:
MFCD00079124
IUPAC Name:
3-(4-phenylpiperazin-1-yl)propane-1,2-diol
InChI:
InChI=1S/C13H20N2O2/c16-11-13(17)10-14-6-8-15(9-7-14)12-4-2-1-3-5-12/h1-5,13,16-17H,6-11H2
InChI Key:
PTVWPYVOOKLBCG-UHFFFAOYSA-N
SMILES:
OCC(CN1CCN(CC1)c1ccccc1)O
EC Number:
241-683-7
NSC Number:
757820
Properties
Complexity:
212  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
236.152g/mol
Formal Charge:
0
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
236.315g/mol
Monoisotopic Mass:
236.152g/mol
Rotatable Bond Count:
4  
Topological Polar Surface Area:
46.9A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
0.6  
Literature
Title Journal
Effects of four antitussives on airway neurogenic inflammation in a guinea pig model of chronic cough induced by cigarette smoke exposure. Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20131201
Efficacy of levodropropizine in pediatric cough. Pulmonary pharmacology & therapeutics 20121001
Levodropropizine in the management of cough associated with cancer or nonmalignant chronic disease--a systematic review. Journal of pain & palliative care pharmacotherapy 20110101
Cough management: a practical approach. Cough (London, England) 20110101
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
An anaphylactic reaction caused by levodropropizine. Allergy 20100301
Sensitive spectrophotometric method for quantitation of guaifenesin and dropropizine in their dosage forms. International journal of analytical chemistry 20100101
The influence of animal species on the relationship between ATP-sensitive potassium ion channels and defense reflexes of the airways. Bratislavske lekarske listy 20090101
HPLC determination and steady-state bioavailability study of levodropropizine sustained-release tablets in dogs. Archives of pharmacal research 20060601
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Rapid and sensitive liquid chromatography-tandem mass spectrometry method for the quantitation of levodropropizine in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20050505
[Determination of levodropropizine and its pharmacokinetics in human plasma using LC/MS/MS]. Yao xue xue bao = Acta pharmaceutica Sinica 20041201
Studies on the human metabolism and the toxicologic detection of the cough suppressant dropropizine in urine using gas chromatography-mass spectrometry. Therapeutic drug monitoring 20040801
Antitussive effect of diltiazem in experimental conditions. Bratislavske lekarske listy 20040101
Levocloperastine in the treatment of chronic nonproductive cough: comparative efficacy versus standard antitussive agents. Drugs under experimental and clinical research 20040101
Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20031225
Chemo-enzymatic synthesis of levodropropizine. Farmaco (Societa chimica italiana : 1989) 20031001
Levodropropizine does not affect P0.1 and breathing pattern in healthy volunteers and patients with chronic respiratory impairment. Pulmonary pharmacology & therapeutics 20030101
Antitussive activity of the fruit extract of Emblica officinalis Gaertn. (Euphorbiaceae). Phytomedicine : international journal of phytotherapy and phytopharmacology 20030101
Properties